SCHEMBL1613781

SCHEMBL1613781

O=C1S/C(=C\c2cc(Br)cc(Br)c2)C(=O)N1Cc1ccccc1C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 2/20 0.53
▸ PPARG P37231 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.45
▸ NLRP3 Q96P20 1/20 0.45
▸ SLC2A1 P11166 2/20 0.44
▸ CHRM5 P08912 1/20 0.42
▸ DVL1 O14640 1/20 0.42
▸ ENPP2 Q13822 2/20 0.41
▸ ESRRA P11474 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1669586 0.85 PIM1 (0.56) PIM1PPARGALDH1A1DVL1ENPP2
SCHEMBL1614943 0.84 PIM1 (0.53) PIM1PPARGALDH1A1NLRP3SLC2A1
SCHEMBL1614720 0.83 SLC2A1 (0.65) PIM1PPARGALDH1A1NLRP3SLC2A1
SCHEMBL12712452 0.81 PIM1 (0.50) PIM1PPARGALDH1A1NLRP3SLC2A1
SCHEMBL12712433 0.80 SLC2A1 (0.56) PIM1PPARGALDH1A1NLRP3SLC2A1
SCHEMBL1614757 0.80 ENPP2 (0.61) PPARGALDH1A1ENPP2MEN1KMT2A
SCHEMBL8689406 0.77 PIM1 (0.44) PIM1ALDH1A1MEN1KMT2A
SCHEMBL1614334 0.73 ENPP2 (0.54) PIM1PPARGALDH1A1ENPP2MEN1
SCHEMBL2174422 0.72 SLC2A1 (0.60) PIM1PPARGALDH1A1NLRP3SLC2A1
SCHEMBL12406528 0.72 SLC2A1 (0.60) PIM1PPARGALDH1A1NLRP3SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488027-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS The Ohio State University Research Foundation (US) 2012-08-22 — — EP claimed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — WO claimed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US claimed
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 — — US disclosed
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 — — US disclosed
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 — — US disclosed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — WO disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS PCK2, AK2, SIRT6 PIM1 2193/4885PPARG 18/4885ALDH1A1 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback